Literature DB >> 20180245

Pathological differential diagnosis of solid-pseudopapillary neoplasm and endocrine tumors of the pancreas.

Bao-An Liu1, Zhuo-Ming Li, Zhan-San Su, Xiao-Ling She.   

Abstract

AIM: To investigate differential points of solid-pseudopapillary neoplasm (SPN) of the pancreas and pancreatic endocrine tumor (PET).
METHODS: Ten cases of SPN and fourteen cases of PET were studied in this retrospective study. Clinical and pathologic features, immunostaining reactions and beta-catenin gene mutations were analyzed.
RESULTS: The mean age of SPN patients was 25.6 years and these patients had no specific symptoms. The mean diameter of the tumors was 11.0 cm, 9/10 cases were cystic or a mixture of solid and cystic structures, and there was hemorrhage and necrosis on the cut surface in 8/10 (80%) cases. Characteristic pseudopapillary structure and discohesive appearance of the neoplastic cells were observed in all 10 (100%) cases. The results of immunostaining showed that nuclear expression of beta-catenin and loss of E-cadherin in all the cases, was only seen in SPN. Molecular studies discovered that 9/10 (90%) cases harbored a point mutation of exon 3 in beta-catenin gene. On the other hand, the mean age of PET patients was 43.1 years. Eight of 14 cases presented with symptoms caused by hypoglycemia, and the other 6 cases presented with symptoms similar to those of SPN. The mean size of the tumors was 2.9 cm, most of the tumors were solid, only 3/14 (21%) were a mixture of solid and cystic structures, and macroscopic hemorrhage and necrosis were much less common (3/14, 21%). Histologically, tumor cells were arranged in trabecular, acinar or solid patterns and demonstrated no pseudopapillary structure and discohesive appearance in all 14 (100%) cases. The results of immunostaining and mutation detection were completely different with SPN that membrane and cytoplastic expression of beta-catenin without loss of E-cadherin, as well as no mutation in beta-catenin gene in all the cases.
CONCLUSION: Both macroscopic and microscopic features of SPN are quite characteristic. It is not difficult to distinguish it from PET. If necessary, immunostaining of beta-catenin and E-cadherin is quite helpful to make the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180245      PMCID: PMC2828590          DOI: 10.3748/wjg.v16.i8.1025

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Solid pseudopapillary tumour of the pancreas.

Authors:  Vincenzo Canzonieri; Massimiliano Berretta; Angela Buonadonna; Massimo Libra; Enrico Vasquez; Emilia Barbagallo; Alessandra Bearz; Salvatore Berretta
Journal:  Lancet Oncol       Date:  2003-04       Impact factor: 41.316

2.  Solid pseudopapillary tumors of the pancreas: diagnosis and curative treatment.

Authors:  R Frago; J Fabregat; R Jorba; F García-Borobia; J Altet; M T Serrano; C Valls
Journal:  Rev Esp Enferm Dig       Date:  2006-11       Impact factor: 2.086

Review 3.  Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information.

Authors:  M R Wick; F M Graeme-Cook
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

Review 4.  Less common neoplasms of the pancreas.

Authors:  Abby-L Mulkeen; Peter-S Yoo; Charles Cha
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

5.  Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients.

Authors:  Roberto Salvia; Claudio Bassi; Leonardina Festa; Massimo Falconi; Stefano Crippa; Giovanni Butturini; Antonietta Brighenti; Paola Capelli; Paolo Pederzoli
Journal:  J Surg Oncol       Date:  2007-03-15       Impact factor: 3.454

6.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.

Authors:  Mi-Jung Kim; Se-Jin Jang; Eunsil Yu
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

Review 8.  Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas.

Authors:  S Serra; R Chetty
Journal:  J Clin Pathol       Date:  2008-08-15       Impact factor: 3.411

9.  Management of nonfunctioning islet cell tumors.

Authors:  Han Liang; Pu Wang; Xiao-Na Wang; Jia-Cang Wang; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

10.  Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal.

Authors:  M Kosmahl; U Pauser; K Peters; B Sipos; J Lüttges; B Kremer; G Klöppel
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

View more
  17 in total

1.  Solid pseudopapillary tumour of the pancreas in an 11-year-old Iranian girl.

Authors:  Ali Akhavan; Fariba Binesh; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-06-21

2.  Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.

Authors:  Zina Meriden; Chanjuan Shi; Barish H Edil; Trevor Ellison; Christopher L Wolfgang; Toby C Cornish; Richard D Schulick; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2011-07       Impact factor: 6.394

3.  Does Computed Tomography Have the Ability to Differentiate Aggressive From Nonaggressive Solid Pseudopapillary Neoplasm?

Authors:  Ashita Rastogi; Mathew Assing; Mellisa Taggart; Brinda Rao; Jia Sun; Khaled Elsayes; Eric Tamm; Priya Bhosale
Journal:  J Comput Assist Tomogr       Date:  2018 May/Jun       Impact factor: 1.826

4.  Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.

Authors:  Peyman Dinarvand; Wei-Lien Wang; Sinchita Roy-Chowdhuri
Journal:  Cytopathology       Date:  2021-12-05       Impact factor: 2.073

5.  Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas.

Authors:  Elisa Rodriguez-Matta; Amanda Hemmerich; Jason Starr; Kabir Mody; Eric A Severson; Gerardo Colon-Otero
Journal:  Acta Oncol       Date:  2020-07-16       Impact factor: 4.089

6.  Clinicopathologic characteristics and surgical treatment of solid pseudopapillary tumor of the pancreas.

Authors:  Y Huang; J F Feng
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

7.  Solid pseudopapillary neoplasm of the pancreas: a case report with review of the diagnostic dilemmas and tumor behavior.

Authors:  Ritu Lakhtakia; Khalifa Al-Wahaibi; Khawaja F Zahid; Kamran A Malik; Ikram A Burney
Journal:  Oman Med J       Date:  2013-11

8.  CTNNB1 mutational analysis of solid-pseudopapillary neoplasms of the pancreas using endoscopic ultrasound-guided fine-needle aspiration and next-generation deep sequencing.

Authors:  Yoshimasa Kubota; Hiroshi Kawakami; Mitsuteru Natsuizaka; Kazumichi Kawakubo; Katsuji Marukawa; Taiki Kudo; Yoko Abe; Kimitoshi Kubo; Masaki Kuwatani; Yutaka Hatanaka; Tomoko Mitsuhashi; Yoshihiro Matsuno; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2014-04-04       Impact factor: 7.527

9.  Solid pseudopapillary tumor of the pancreas and concomitant urogenital malformations in a young woman.

Authors:  Zhi-Wei Guan; Lu Sun; Yan-Qiu Wang; Bai-Xuan Xu
Journal:  Diagn Pathol       Date:  2013-02-27       Impact factor: 2.644

10.  E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.

Authors:  Eike Burandt; Felix Lübbersmeyer; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Anne Menz; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Frank Jacobsen; Patrick Lebok; Till Sebastian Clauditz; Guido Sauter; Ronald Simon; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Rainer Krech; David Dum; Till Krech; Andreas Holger Marx; Christian Bernreuther
Journal:  Biomark Res       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.